Sponsor: ThermoFisher Scientific. Large cohort studies are essential to the discovery of protein biomarkers, and their validation is indispensable to clinical utility.
Sponsor: ThermoFisher Scientific. Coupling relatively routine datasets such as genomes and transcriptomes with newer types produces an “integrative Personal Omics Profile".
Sponsor: ThermoFisher Scientific. In this webinar, multiplexing quantitative proteomics for profiling breast cancer patient-derived xenografts will be discussed.
Sponsor: ThermoFisher Scientific. This webinar will discuss new technology developments and optimization of each component in the translational proteomics workflow.
Sponsor: QIAGEN. This webinar explores the complexity of diagnostic testing in immuno-oncology and therapeutic innovations that have emerged in the field.
Sponsor: ThermoFisher Scientific. The webinar will focus on some of the current challenges facing researchers looking to improve biomarker discovery for ovarian cancer.
Sponsor: QIAGEN. This groundbreaking webinar will discuss how NGS technologies have aided clinicians in the diagnosis and treatment of hematologic cancer.
We use cookies to give you a better experience on clinicalomics.com. By continuing to use our site, you are agreeing to the use of cookies as set in our privacy policy.
![A liquid biopsy test has detected changes in the BRCA1 or BRCA2 genes associated with ovarian and breast cancer that signal when the disease stops responding to treatment through platinum chemotherapy or poly ADP-ribose polymerase (PARP) inhibitors. [Source: © freshidea/Fotolia]](https://www.clinicalomics.com/wp-content/uploads/2019/01/1322-218x150.jpeg "Ovarian Cancer Blood Test May Eliminate Need for Diagnostic Exploratory Surgery")
![Diagnostic firms are working to create new tests that can detect rheumatoid arthritis earlier and also provide risk assessment profiles of patients that are more or less likely to suffer permanent physical damage as a result of the disease. [©Puwadol Jaturawutthichai/Shutterstock]](https://www.clinicalomics.com/wp-content/uploads/2019/01/169-218x150.jpeg "New Targets Identified For Lupus and Rheumatoid Arthritis")
